Aligos Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-07. The offering totals $92.2M, of which $92.2M was reported sold. Industry: Biotechnology.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Leonid Beigelman | Director | South San Francisco, CA |
| Lawrence Blatt | Director | South San Francisco, CA |
| Peter Ann Hirth | Director | South San Francisco, CA |
| Bridget Ann Martell | Director | South San Francisco, CA |
| Jack Ann Nielsen | Director | South San Francisco, CA |
| Carole Ann Nuechterlein | Director | South San Francisco, CA |
| James Ann Scopa | Director | South San Francisco, CA |
| Leonid Beigelman | Executive Officer | South San Francisco, CA |
| Lawrence Blatt | Executive Officer | South San Francisco, CA |
| Matthew Ann McClure | Executive Officer | South San Francisco, CA |
| Lucinda Ann Quan | Executive Officer | South San Francisco, CA |
| Julian Ann Symons | Executive Officer | South San Francisco, CA |
| Lesley Ann Calhoun | Executive Officer | Boston, MA |
| Bridget Peter Martell | Director | South San Francisco, CA |
| Julian Peter Symons | Executive Officer | South San Francisco, CA |
| Margarita Peter Chavez | Director | South San Francisco, CA |
| K. Peter Hirth | Director | South San Francisco, CA |
| Heather Peter Preston | Director | South San Francisco, CA |
| Lawrence M Blatt | Director | South San Francisco, CA |
| Lawrence M Blatt | Executive Officer | South San Francisco, CA |
| James Peter Scopa | Director | South San Francisco, CA |
| Hardean Peter Achneck | Executive Officer | South San Francisco, CA |
| Carole Peter Nuechterlein | Director | South San Francisco, CA |
| Peter Hirth | Director | South San Francisco, CA |
| Tom Woiwode | Director | Del Mar, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-02-28 | D | $105.0M | $105.0M |
| 2020-01-16 | D | $125.0M | $85.0M |